Main
>
GASTROENTEROLOGY
>
Inflammatory Bowel Disease (IBD)
>
Treatment
>
DHODH Inhibitor (Vidofludimus)
>
Co.: DE. 4. Phase IIA
>
UpDate: 11.02.2012
UpDate: 11.02.2012's products
This section has no products